These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 96138)
1. Deoxyguanosine triphosphate as a possible toxic metabolite in the immunodeficiency associated with purine nucleoside phosphorylase deficiency. Cohen A; Gudas LJ; Ammann AJ; Staal GE; Martin DW J Clin Invest; 1978 May; 61(5):1405-9. PubMed ID: 96138 [TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of deoxyguanosine by B and T lymphocytes: evidence against selective trapping of deoxyguanosine by T lymphocytes in purine nucleoside phosphorylase deficiency. North ME; Newton CA; Webster AD Clin Exp Immunol; 1980 Dec; 42(3):523-9. PubMed ID: 6783354 [TBL] [Abstract][Full Text] [Related]
3. [Immune insufficiency in enzyme defects of purine metabolism]. Müller G Z Gesamte Inn Med; 1983 Feb; 38(3):83-9. PubMed ID: 6303005 [TBL] [Abstract][Full Text] [Related]
4. Deoxyribonucleoside toxicity in adenosine deaminase and purine nucleoside phosphorylase deficiency: implications for the development of new immunosuppressive agents. Carson DA; Kaye J Ciba Found Symp; 1978; (68):115-33. PubMed ID: 115660 [TBL] [Abstract][Full Text] [Related]
10. Partial deficiency of purine nucleoside phosphorylase: studies of purine and pyrimidine metabolism. Edwards NL; Gelfand EW; Biggar D; Fox IH J Lab Clin Med; 1978 May; 91(5):736-49. PubMed ID: 417142 [No Abstract] [Full Text] [Related]
11. Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase and their implications for therapy of leukemias. Hirschhorn R; Ratech H Curr Top Hematol; 1983; 4():1-35. PubMed ID: 6413135 [No Abstract] [Full Text] [Related]
12. Purine nucleoside phosphorylase deficiency. Evidence for molecular heterogeneity in two families with enzyme-deficient members. Osborne WR; Chen SH; Giblett ER; Biggar WD; Ammann AA; Scott CR J Clin Invest; 1977 Sep; 60(3):741-6. PubMed ID: 408378 [TBL] [Abstract][Full Text] [Related]
13. Purine nucleoside metabolism in the erythrocytes of patients with adenosine deaminase deficiency and severe combined immunodeficiency. Agarwal RP; Crabtree GW; Parks RE; Nelson JA; Keightley R; Parkman R; Rosen FS; Stern RC; Polmar SH J Clin Invest; 1976 Apr; 57(4):1025-35. PubMed ID: 947948 [TBL] [Abstract][Full Text] [Related]
14. Adenosine deaminase (ADA) and other enzyme abnormalities in immune deficiency states. Goldblum RM; Schmalstieg FC; Nelson JA; Mills GC Birth Defects Orig Artic Ser; 1978; 14(6A):73-84. PubMed ID: 215243 [No Abstract] [Full Text] [Related]
15. Screening for primary immunodeficiencies associated with purine nucleoside phosphorylase deficiency or adenosine deaminase deficiency. Ito K; Sakura N; Usui T; Uchino H J Lab Clin Med; 1977 Nov; 90(5):844-8. PubMed ID: 409794 [TBL] [Abstract][Full Text] [Related]
19. Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: possible role of nucleoside kinase(s). Carson DA; Kaye J; Seegmiller JE Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5677-81. PubMed ID: 202960 [TBL] [Abstract][Full Text] [Related]
20. Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase: overview, genetic heterogeneity and therapy. Hirschhorn R Birth Defects Orig Artic Ser; 1983; 19(3):73-81. PubMed ID: 6418227 [No Abstract] [Full Text] [Related] [Next] [New Search]